speb/financial-data huggingface dataset:
Financial ratios for SNT — quarterly report dated 2025-09-30
Total revenue: 6834532.37410072
Gross profit: 4598561.151079137
Operating income: 825899.2805755397
Net income: 723741.0071942447
Capital expenditures: 0
Net tangible assets: 22844604.316546764
Owner earnings: 723741.0071942447
Return on net tangible assets (%): 3.168104805693771
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.99
P/E ratio: 33.72547457363702
Shares outstanding: 23331653
Book value: 30718705.035971228
P/B ratio: 3.7900343889388504
Market cap (USD): 116424948.47
Debt to equity: 0.008571629312161877
Current ratio: 4.349318801089918
Quick ratio: 3.743106267029973
Effective tax rate (%): 29.65034965034965
COGS to revenue (%): 32.71578947368421
R&D to revenue (%): 8.547368421052633
SG&A to revenue (%): 46.652631578947364
Buyback yield (%): 0
Retained earnings: -2815827.3381294967
Inventory turnover: 0.5587918015102481
Receivables turnover: 0.7496251874062968
Capitalized R&D asset: 1232010.9549642713
ROCI (R&D-adjusted, %): 2.3545973189259057
Rosenberg metric: -0.08885691446842413
Revenue growth (%): -3.0110901955874647
Rule of 40 score: -3.0110901955874647
Financial ratios for SNT — quarterly report dated 2025-12-31
Total revenue: 6402919.708029197
Gross profit: 3935766.423357664
Operating income: -116058.39416058394
Net income: -24087.59124087591
Capital expenditures: 0
Net tangible assets: 23521167.883211676
Owner earnings: -24087.59124087591
Return on net tangible assets (%): -0.10240814299900697
Buffett classification: The Gruesome
Stock price: 4.83
P/E ratio: 48.8759498913522
Shares outstanding: 23331653
Book value: 31544525.547445253
P/B ratio: 3.5724704060139763
Market cap (USD): 112691883.99
Debt to equity: 0.012911884487226953
Current ratio: 4.519535141117875
Quick ratio: 3.9007194244604313
COGS to revenue (%): 38.531691746466024
R&D to revenue (%): 8.390332877336983
SG&A to revenue (%): 54.890560875512996
Buyback yield (%): 0
Retained earnings: -2880291.9708029195
Inventory turnover: 0.6045430155607225
Receivables turnover: 0.8032231480633641
Capitalized R&D asset: 1145410.2819933835
ROCI (R&D-adjusted, %): -0.4980815626978066
Rosenberg metric: -1.134587033907447
Revenue growth (%): -6.315174798309651
Rule of 40 score: -6.315174798309651
Financial ratios for SNT — annual report dated 2025-12-31
Total revenue: 26550364.963503648
Gross profit: 17399270.0729927
Operating income: 2197080.291970803
Net income: 2348175.182481752
Capital expenditures: 408029.1970802919
Operating cash flow: 1281021.8978102189
Depreciation & amortization: 493430.65693430655
Net tangible assets: 23521167.883211676
Owner earnings: 2433576.6423357665
Return on net tangible assets (%): 10.34632571996028
Capex to operating income (%): 18.57142857142857
Buffett classification: The Great
Stock price: 4.83
P/E ratio: 47.99125926835561
Shares outstanding: 23331653
Book value: 31544525.547445253
P/B ratio: 3.5724704060139763
Market cap (USD): 112691883.99
Debt to equity: 0.012911884487226953
Current ratio: 4.519535141117875
Quick ratio: 3.9007194244604313
Effective tax rate (%): -4.414151249594288
Interest coverage ratio: 20.758620689655174
COGS to revenue (%): 34.466926925826144
R&D to revenue (%): 9.204376752625501
SG&A to revenue (%): 48.05355473689998
Free cash flow (dilution-adjusted): 426277.3722627737
Buyback yield (%): 0
Retained earnings: -2880291.9708029195
Inventory turnover: 2.2423537828653193
Receivables turnover: 3.330647376613863
Capitalized R&D asset: 5389919.746312082
ROCI (R&D-adjusted, %): 4.773585874821857
Rosenberg metric: 0.4731284520307304
FCF margin (%): 1.6055424204101831
Revenue growth (%): 6.192548591195744
Rule of 40 score: 7.798091011605927
Financial ratios for SRV — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.3
Shares outstanding: 4667609
Market cap (USD): 80749635.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRV — annual report dated 2022-11-30
Total revenue: 18389324
Net income: 18041970
Capital expenditures: 0
Operating cash flow: 32163143
Net tangible assets: 93160415
Owner earnings: 18041970
Return on net tangible assets (%): 19.366562504042086
Buffett classification: The Gruesome
Stock price: 20.81
P/E ratio: 5.383721583064377
Shares outstanding: 4667609
Book value: 93160415
P/B ratio: 1.0426418054277666
Market cap (USD): 97132943.28999999
Debt to equity: 0.07852047460286646
COGS to revenue (%): 0
SG&A to revenue (%): 3.3017853184815276
Free cash flow (dilution-adjusted): 32163143
Buyback yield (%): 0
Retained earnings: -4039467
Receivables turnover: 94.93321907200529
Capitalized R&D asset: 0
FCF margin (%): 174.90117091851772
Rule of 40 score: 174.90117091851772
Financial ratios for SRV — annual report dated 2023-11-30
Total revenue: 3764377
Net income: 3378759
Capital expenditures: 0
Operating cash flow: -292705
Net tangible assets: 84805681
Owner earnings: 3378759
Return on net tangible assets (%): 3.9841187054438016
Buffett classification: The Gruesome
Stock price: 23.97
P/E ratio: 33.11351526699596
Shares outstanding: 4667609
Book value: 84805681
P/B ratio: 1.3192817557823748
Market cap (USD): 111882587.72999999
Debt to equity: 0.227755968376694
COGS to revenue (%): 0
SG&A to revenue (%): 16.339649296550267
Free cash flow (dilution-adjusted): -292705
Buyback yield (%): 0
Retained earnings: -2959410
Receivables turnover: 7.8473076049138735
Capitalized R&D asset: 0
FCF margin (%): -7.775655838934305
Revenue growth (%): -79.52955203791069
Rule of 40 score: -87.30520787684499
Financial ratios for SRV — annual report dated 2024-11-30
Total revenue: 15438924.71
Net income: 57802892
Capital expenditures: 0
Operating cash flow: -81352221
Net tangible assets: 194958809
Owner earnings: 57802892
Return on net tangible assets (%): 29.648771602826113
Buffett classification: The Gruesome
Stock price: 36.35
P/E ratio: 2.935278517725376
Shares outstanding: 4667609
Book value: 194958809
P/B ratio: 0.8702740236272165
Market cap (USD): 169667587.15
Debt to equity: 0.24782157958299797
COGS to revenue (%): 0
SG&A to revenue (%): 10.200930632040112
Free cash flow (dilution-adjusted): -81352221
Buyback yield (%): 0
Retained earnings: 40414780
Receivables turnover: 2.139687934437835
Capitalized R&D asset: 0
FCF margin (%): -526.9293200666175
Revenue growth (%): 310.13226650784446
Rule of 40 score: -216.79705355877303
Financial ratios for SRV — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 194958809
Buffett classification: The Gruesome
Stock price: 36.35
Shares outstanding: 4667609
Book value: 194958809
P/B ratio: 0.8702740236272165
Market cap (USD): 169667587.15
Debt to equity: 0.24782157958299797
Buyback yield (%): 0
Retained earnings: 40414780
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRV — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 180537263
Buffett classification: The Gruesome
Stock price: 33.45
Shares outstanding: 4667609
Book value: 180537263
P/B ratio: 0.8648160410518687
Market cap (USD): 156131521.05
Debt to equity: 0.3340861548344178
Buyback yield (%): 0
Retained earnings: 17696694
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNIE.DE — annual report dated 2021-12-31
Total revenue: 213605681.8181818
Gross profit: 115640909.0909091
Operating income: -297667045.45454544
Net income: -273301136.3636364
Capital expenditures: 3759090.909090909
Operating cash flow: -30032954.545454547
Depreciation & amortization: 16138636.363636363
Net tangible assets: -172727.27272727274
Owner earnings: -260921590.9090909
Buffett classification: The Gruesome
Stock price: 13.295454545454545
Shares outstanding: 114400747
Book value: 319655681.8181819
P/B ratio: 4.758275914424966
Market cap (USD): 1521009931.7045455
Debt to equity: 0.004322833162102688
Current ratio: 1.23118771787739
Quick ratio: 0.9536251276453397
Interest coverage ratio: -41.10907093534212
COGS to revenue (%): 45.862437690519386
SG&A to revenue (%): 24.986035228463663
Free cash flow (dilution-adjusted): -42639772.72727273
Buyback yield (%): 0
Retained earnings: -302942045.45454544
Inventory turnover: 2.73418966064066
Receivables turnover: 8.42512661915647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -80.73919047208076
FCF margin (%): -19.961909423161835
Rule of 40 score: -19.961909423161835
Financial ratios for TNIE.DE — annual report dated 2022-12-31
Total revenue: 274768085.10638297
Gross profit: 114511702.12765957
Operating income: -65493617.0212766
Net income: -33684042.55319149
Capital expenditures: 3621276.595744681
Operating cash flow: -79129787.23404256
Depreciation & amortization: 19589361.70212766
Net tangible assets: 61493617.0212766
Owner earnings: -17715957.44680851
Return on net tangible assets (%): -28.809424953290424
Buffett classification: The Gruesome
Stock price: 6.382978723404256
Shares outstanding: 114400747
Book value: 355997872.34042555
P/B ratio: 2.051185107489287
Market cap (USD): 730217534.0425533
Debt to equity: 0.037129674454186315
Current ratio: 1.7650595783684693
Quick ratio: 0.9921723189734187
Interest coverage ratio: -54.52967227635076
COGS to revenue (%): 58.32423475116346
SG&A to revenue (%): 28.1846973463114
Free cash flow (dilution-adjusted): -119334042.5531915
Buyback yield (%): 0
Retained earnings: -314676595.7446809
Inventory turnover: 1.7864969995967837
Receivables turnover: 7.423603127155666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.516872622299015
FCF margin (%): -43.43082367334929
Revenue growth (%): 28.633322282251715
Rule of 40 score: -14.797501391097573
Financial ratios for TNIE.DE — annual report dated 2023-12-31
Total revenue: 401053333.3333333
Gross profit: 206808888.8888889
Operating income: -21016666.666666668
Net income: -13118888.888888888
Capital expenditures: 4477777.777777778
Operating cash flow: 9047777.777777778
Depreciation & amortization: 21644444.444444444
Net tangible assets: 60567777.777777776
Owner earnings: 4047777.777777778
Buffett classification: The Gruesome
Stock price: 5.833333333333333
Shares outstanding: 114400747
Book value: 361463333.3333334
P/B ratio: 1.8462113008235042
Market cap (USD): 667337690.8333333
Debt to equity: 0.08792039764291444
Current ratio: 1.644726102652645
Quick ratio: 1.0477319102181761
Interest coverage ratio: -7.569027611044419
COGS to revenue (%): 48.43356937841462
SG&A to revenue (%): 28.568103992818912
Free cash flow (dilution-adjusted): -10884444.444444444
Buyback yield (%): 0
Retained earnings: -341781111.1111111
Inventory turnover: 2.2981766554049616
Receivables turnover: 7.3557774607703275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.183157410147644
FCF margin (%): -2.713964338353447
Revenue growth (%): 45.96066831344551
Rule of 40 score: 43.24670397509206
Financial ratios for TNIE.DE — annual report dated 2024-12-31
Total revenue: 500568750
Gross profit: 253659375
Operating income: 6211458.333333334
Net income: 13628125
Capital expenditures: 3716666.666666667
Operating cash flow: 49129166.66666667
Depreciation & amortization: 21622916.666666668
Net tangible assets: 83631250
Owner earnings: 31534375.000000004
Return on net tangible assets (%): 37.706449443240416
Capex to operating income (%): 59.835653194700654
Buffett classification: The Good
Stock price: 7.895833333333334
P/E ratio: 66.28125523656654
Shares outstanding: 114400747
Book value: 360825000.00000006
P/B ratio: 2.503399796357883
Market cap (USD): 903289231.5208334
Debt to equity: 0.05878311277396706
Current ratio: 1.6314595381810084
Quick ratio: 1.0953607471911124
Effective tax rate (%): -159.06930693069307
Interest coverage ratio: 1.8781102362204725
COGS to revenue (%): 49.325975036729055
SG&A to revenue (%): 28.266388649577774
Free cash flow (dilution-adjusted): 32282291.666666668
Buyback yield (%): 0
Retained earnings: -306518750
Inventory turnover: 2.660821930110122
Receivables turnover: 6.245561591848405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5199055889602295
FCF margin (%): 6.449122456539021
Revenue growth (%): 24.813511918614324
Rule of 40 score: 31.262634375153347
Financial ratios for TNIE.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 83631250
Buffett classification: The Gruesome
Stock price: 7.895833333333334
Shares outstanding: 114400747
Book value: 360825000.00000006
P/B ratio: 2.503399796357883
Market cap (USD): 903289231.5208334
Debt to equity: 0.05878311277396706
Current ratio: 1.6314595381810084
Quick ratio: 1.0953607471911124
Buyback yield (%): 0
Retained earnings: -306518750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNIE.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 87248235.29411764
Buffett classification: The Gruesome
Stock price: 7.011764705882353
Shares outstanding: 114400747
Book value: 397542352.9411764
P/B ratio: 2.0177752488673057
Market cap (USD): 802151120.1411765
Debt to equity: 0.041022636137917984
Current ratio: 1.682018273681663
Quick ratio: 0.6091504553293197
Buyback yield (%): 0
Retained earnings: -347490588.2352941
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRMED.OL — annual report dated 2021-12-31
Capital expenditures: 29431.81818181818
Buffett classification: The Gruesome
Stock price: 2.5929304446978336
Shares outstanding: 360001820
Market cap (USD): 933459679.2246294
Buyback yield (%): 0
Capitalized R&D asset: 36134204.54545454
Rule of 40 score: 0
Financial ratios for TRMED.OL — annual report dated 2022-12-31
Total revenue: 0
Operating income: 0
Net income: -31502125.50607287
Capital expenditures: 569635.6275303643
Operating cash flow: -41404757.08502024
Depreciation & amortization: 1133805.6680161941
Net tangible assets: 6461740.890688258
Owner earnings: -30937955.465587042
Return on net tangible assets (%): -478.7866921462361
Buffett classification: The Gruesome
Stock price: 0.11842105263157893
Shares outstanding: 360001820
Book value: 6461740.890688259
P/B ratio: 6.597571025343816
Market cap (USD): 42631794.47368421
Debt to equity: 0.002490523479840857
Current ratio: 2.4638800442607773
Quick ratio: 2.4638800442607773
Free cash flow (dilution-adjusted): -41640182.18623482
Buyback yield (%): 0
Retained earnings: -2622975.708502024
Capitalized R&D asset: 24209917.045454543
ROCI (R&D-adjusted, %): -39.07392662038106
Rule of 40 score: 0
Financial ratios for TRMED.OL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -703634.5776031434
Net income: -2609037.3280943027
Capital expenditures: 0
Operating cash flow: -6295677.799607073
Depreciation & amortization: 70432.22003929273
Net tangible assets: -1233398.8212180748
Owner earnings: -2538605.10805501
Buffett classification: The Gruesome
Stock price: 0.12671905697445973
Shares outstanding: 360001820
Book value: 26711689.587426327
P/B ratio: 1.7078324824859796
Market cap (USD): 45619091.139489196
Debt to equity: 0
Current ratio: 10.19928025191183
Quick ratio: 10.19928025191183
Free cash flow (dilution-adjusted): -6501964.63654224
Buyback yield (%): 0
Retained earnings: -2048330.0589390963
Capitalized R&D asset: 12017116.576620823
ROCI (R&D-adjusted, %): -28.781303775315433
Rule of 40 score: 0
Financial ratios for TRMED.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4775375.110326567
Buffett classification: The Gruesome
Stock price: 0.23192239858906524
Shares outstanding: 360001820
Book value: 29756751.9858782
P/B ratio: 2.8058332989585804
Market cap (USD): 83492485.59082893
Debt to equity: 0.0021860095389507153
Current ratio: 5.672969432314411
Quick ratio: 5.672969432314411
Buyback yield (%): 0
Retained earnings: -5565754.633715799
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRMED.OL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -3874669.0203000885
Net income: -3724624.8896734333
Capital expenditures: 8826.1253309797
Operating cash flow: -2091791.703442189
Depreciation & amortization: 211827.00794351278
Net tangible assets: 4775375.110326567
Owner earnings: -3521624.0070609
Return on net tangible assets (%): -73.74549487108399
Buffett classification: The Gruesome
Stock price: 0.23192239858906524
Shares outstanding: 360001820
Book value: 29756751.9858782
P/B ratio: 2.8058332989585804
Market cap (USD): 83492485.59082893
Debt to equity: 0.0021860095389507153
Current ratio: 5.672969432314411
Quick ratio: 5.672969432314411
Interest coverage ratio: -439.00000000000006
Free cash flow (dilution-adjusted): -2347749.3380406
Buyback yield (%): 0
Retained earnings: -5565754.633715799
Capitalized R&D asset: 354251.96853807115
ROCI (R&D-adjusted, %): -10.630965746689185
Rule of 40 score: 0
Financial ratios for TRMED.OL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 19851042.70109235
Buffett classification: The Gruesome
Stock price: 0.253227408142999
Shares outstanding: 360001820
Book value: 47020854.02184707
P/B ratio: 1.9387637613516369
Market cap (USD): 91162327.80536246
Debt to equity: 0.018373812038014782
Current ratio: 8.87142857142857
Quick ratio: 8.778571428571428
Buyback yield (%): 0
Retained earnings: -9215491.559086395
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSLA.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.952755905511811
Shares outstanding: 59228495590
Market cap (USD): 530258263667.95276
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSLA.TO — annual report dated 2022-12-31
Total revenue: 81462000000
Gross profit: 20853000000
Operating income: 13832000000
Net income: 12587000000
Capital expenditures: 7163000000
Operating cash flow: 14724000000
Depreciation & amortization: 3747000000
Net tangible assets: 44111000000
Owner earnings: 9171000000
Return on net tangible assets (%): 20.790732470358865
Capex to operating income (%): 51.78571428571429
Buffett classification: The Good
Stock price: 8.588235294117647
P/E ratio: 40.41219164562877
Shares outstanding: 59228495590
Book value: 45898000000
P/B ratio: 11.082579987004431
Market cap (USD): 508668256243.5294
Debt to equity: 0.12523421499847487
Current ratio: 1.53195552061103
Quick ratio: 1.0512561308922086
Effective tax rate (%): 8.251330271885706
Interest coverage ratio: 72.41884816753927
COGS to revenue (%): 74.401561464241
R&D to revenue (%): 3.7747661486337187
SG&A to revenue (%): 4.843976332523139
Free cash flow (dilution-adjusted): 5992000000
Buyback yield (%): 0
Retained earnings: 12885000000
Inventory turnover: 4.720694758158735
Receivables turnover: 27.59552845528455
Capitalized R&D asset: 3075000000
ROCI (R&D-adjusted, %): 27.054374488961567
FCF margin (%): 7.3555768333701605
Rule of 40 score: 7.3555768333701605
Financial ratios for TSLA.TO — annual report dated 2023-12-31
Total revenue: 96773000000
Gross profit: 17660000000
Operating income: 8891000000
Net income: 14999000000
Capital expenditures: 8899000000
Operating cash flow: 13256000000
Depreciation & amortization: 4667000000
Net tangible assets: 62019000000
Owner earnings: 10767000000
Return on net tangible assets (%): 17.36080878440478
Capex to operating income (%): 100.08997863007536
Buffett classification: The Gruesome
Stock price: 17.424242424242422
P/E ratio: 68.80536472987087
Shares outstanding: 59228495590
Book value: 63609000000
P/B ratio: 16.22430262358052
Market cap (USD): 1032011665583.3333
Debt to equity: 0.15049757109842946
Current ratio: 1.7258939752330598
Quick ratio: 1.2519131765688047
Effective tax rate (%): -50.14539255991176
Interest coverage ratio: 56.993589743589745
COGS to revenue (%): 81.75110826366858
R&D to revenue (%): 4.101350583323861
SG&A to revenue (%): 4.960061174087814
Free cash flow (dilution-adjusted): 2545000000
Buyback yield (%): 0
Retained earnings: 27882000000
Inventory turnover: 5.806032584764421
Receivables turnover: 27.5863740022805
Capitalized R&D asset: 6029250000
ROCI (R&D-adjusted, %): 12.529313432480027
Rosenberg metric: -1.0383739837398374
FCF margin (%): 2.629865768344476
Revenue growth (%): 18.795266504627925
Rule of 40 score: 21.4251322729724
Financial ratios for TSLA.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.703703703703702
Shares outstanding: 59228495590
Market cap (USD): 1048563736741.4814
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSLA.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.74825174825175
Shares outstanding: 59228495590
Market cap (USD): 1525030215121.5386
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSLA.TO — annual report dated 2024-12-31
Total revenue: 97690000000
Gross profit: 17450000000
Operating income: 7760000000
Net income: 7153000000
Capital expenditures: 11342000000
Operating cash flow: 14923000000
Depreciation & amortization: 5368000000
Net tangible assets: 71443000000
Owner earnings: 1179000000
Return on net tangible assets (%): 1.6502666461374802
Capex to operating income (%): 146.159793814433
Buffett classification: The Gruesome
Stock price: 25.74825174825175
P/E ratio: 213.20148400972158
Shares outstanding: 59228495590
Book value: 73680000000
P/B ratio: 20.698021377871047
Market cap (USD): 1525030215121.5386
Debt to equity: 0.18489413680781758
Current ratio: 2.024912390270983
Quick ratio: 1.6079594739946568
Effective tax rate (%): 20.433815350389324
Interest coverage ratio: 22.17142857142857
COGS to revenue (%): 82.1373733237793
R&D to revenue (%): 4.647353874500972
SG&A to revenue (%): 5.271778073497799
Free cash flow (dilution-adjusted): 1582000000
Buyback yield (%): 0
Retained earnings: 35209000000
Inventory turnover: 6.677207289672963
Receivables turnover: 22.111815301041194
Capitalized R&D asset: 8213980000
ROCI (R&D-adjusted, %): 8.316990755314565
Rosenberg metric: -0.05291005291005291
FCF margin (%): 1.6194083324802946
Revenue growth (%): 0.9475783534663594
Rule of 40 score: 2.566986685946654
Financial ratios for TSLA.TO — quarterly report dated 2025-03-31
Total revenue: 19335000000
Gross profit: 3153000000
Operating income: 493000000
Net income: 420000000
Capital expenditures: 1492000000
Operating cash flow: 2156000000
Depreciation & amortization: 1447000000
Net tangible assets: 74261000000
Owner earnings: 375000000
Return on net tangible assets (%): 0.5049756938366033
Capex to operating income (%): 302.6369168356998
Buffett classification: The Gruesome
Stock price: 16.314685314685313
P/E ratio: 575.1751590554029
Shares outstanding: 59228495590
Book value: 75418000000
P/B ratio: 12.812515145099006
Market cap (USD): 966294267213.0768
Debt to equity: 0.17406985069877218
Current ratio: 1.996067623432931
Quick ratio: 1.5354081941316842
Effective tax rate (%): 28.69269949066214
Interest coverage ratio: 5.417582417582418
COGS to revenue (%): 83.69278510473235
R&D to revenue (%): 7.287302818722524
SG&A to revenue (%): 6.470131885182312
Free cash flow (dilution-adjusted): 91000000
Buyback yield (%): 0
Retained earnings: 35618000000
Inventory turnover: 1.180650809864293
Receivables turnover: 5.112374405076679
Capitalized R&D asset: 1409000000
ROCI (R&D-adjusted, %): 1.480187805071288
FCF margin (%): 0.4706490819756918
Rule of 40 score: 0.4706490819756918
Financial ratios for TSLA.TO — quarterly report dated 2025-06-30
Total revenue: 22496000000
Gross profit: 3878000000
Operating income: 923000000
Net income: 1190000000
Capital expenditures: 2394000000
Operating cash flow: 2540000000
Depreciation & amortization: 1433000000
Net tangible assets: 76918000000
Owner earnings: 229000000
Return on net tangible assets (%): 0.2977196494968668
Capex to operating income (%): 259.37161430119176
Buffett classification: The Gruesome
Stock price: 20.76642335766423
P/E ratio: 763.9528038878813
Shares outstanding: 59228495590
Book value: 78072000000
P/B ratio: 15.754227050152279
Market cap (USD): 1229964014259.4888
Debt to equity: 0.16822932677528435
Current ratio: 2.0372234070914423
Quick ratio: 1.5516862170087977
Effective tax rate (%): 23.17624273724984
Interest coverage ratio: 10.732558139534884
COGS to revenue (%): 82.76137980085349
R&D to revenue (%): 7.063477951635846
SG&A to revenue (%): 6.072190611664296
Free cash flow (dilution-adjusted): -489000000
Buyback yield (%): 0
Retained earnings: 36790000000
Inventory turnover: 1.277831159917639
Receivables turnover: 5.861386138613861
Capitalized R&D asset: 2533030000
ROCI (R&D-adjusted, %): 1.4963263341993098
Rosenberg metric: 0.5145493257629524
FCF margin (%): -2.1737197724039827
Revenue growth (%): 16.348590638738038
Rule of 40 score: 14.174870866334055
Financial ratios for TSLA.TO — quarterly report dated 2025-09-30
Total revenue: 28095000000
Gross profit: 5054000000
Operating income: 1862000000
Net income: 1389000000
Capital expenditures: 2248000000
Operating cash flow: 6238000000
Depreciation & amortization: 1625000000
Net tangible assets: 79582000000
Owner earnings: 766000000
Return on net tangible assets (%): 0.9625292151491543
Capex to operating income (%): 120.73039742212674
Buffett classification: The Gruesome
Stock price: 28.431654676258997
P/E ratio: 561.5085473855314
Shares outstanding: 59228495590
Book value: 80716000000
P/B ratio: 20.862829347455385
Market cap (USD): 1683964133609.209
Debt to equity: 0.17082115070122406
Current ratio: 2.0662511984659635
Quick ratio: 1.67392138063279
Effective tax rate (%): 29.096477794793262
Interest coverage ratio: 24.5
COGS to revenue (%): 82.01103399181349
R&D to revenue (%): 5.801744082576971
SG&A to revenue (%): 5.559708133119772
Free cash flow (dilution-adjusted): 3327000000
Buyback yield (%): 0
Retained earnings: 38163000000
Inventory turnover: 1.8769143043336591
Receivables turnover: 5.973846480969594
Capitalized R&D asset: 3159600000
ROCI (R&D-adjusted, %): 1.845879188343437
Rosenberg metric: 0.7400881057268722
FCF margin (%): 11.841964762413241
Revenue growth (%): 24.888869132290186
Rule of 40 score: 36.73083389470342
Financial ratios for TSLA.TO — annual report dated 2025-12-31
Total revenue: 94827000000
Gross profit: 17094000000
Operating income: 4849000000
Net income: 3855000000
Capital expenditures: 8527000000
Operating cash flow: 14747000000
Depreciation & amortization: 6148000000
Net tangible assets: 80748000000
Owner earnings: 1476000000
Return on net tangible assets (%): 1.8279090503789568
Capex to operating income (%): 175.85069086409567
Buffett classification: The Gruesome
Stock price: 28.956204379562042
P/E ratio: 444.8851941369725
Shares outstanding: 59228495590
Book value: 82865000000
P/B ratio: 20.69670456040583
Market cap (USD): 1715032423398.029
Debt to equity: 0.17762625957883305
Current ratio: 2.1644068865485275
Quick ratio: 1.7736646276092578
Effective tax rate (%): 26.960970064418337
Interest coverage ratio: 14.346153846153847
COGS to revenue (%): 81.97348856338384
R&D to revenue (%): 6.760732702711253
SG&A to revenue (%): 6.1522562139475045
Free cash flow (dilution-adjusted): 3395000000
Buyback yield (%): 0
Retained earnings: 39003000000
Inventory turnover: 6.2728373143963845
Receivables turnover: 20.722683566433567
Capitalized R&D asset: 10762570000
ROCI (R&D-adjusted, %): 5.379906551080259
Rosenberg metric: -0.07841409691629955
FCF margin (%): 3.580203950351693
Revenue growth (%): -2.9306991503736306
Rule of 40 score: 0.6495047999780623
Financial ratios for TSLA.TO — quarterly report dated 2025-12-31
Total revenue: 24901000000
Gross profit: 5009000000
Operating income: 1571000000
Net income: 856000000
Capital expenditures: 2393000000
Operating cash flow: 3813000000
Depreciation & amortization: 1643000000
Net tangible assets: 80748000000
Owner earnings: 106000000
Return on net tangible assets (%): 0.13127260117897657
Capex to operating income (%): 152.32336091661364
Buffett classification: The Gruesome
Stock price: 28.956204379562042
P/E ratio: 444.8851941369725
Shares outstanding: 59228495590
Book value: 82865000000
P/B ratio: 20.69670456040583
Market cap (USD): 1715032423398.029
Debt to equity: 0.17762625957883305
Current ratio: 2.1644068865485275
Quick ratio: 1.7736646276092578
Effective tax rate (%): 27.5190516511431
Interest coverage ratio: 18.48235294117647
COGS to revenue (%): 79.88434199429742
R&D to revenue (%): 7.1603550058230585
SG&A to revenue (%): 6.646319424922694
Free cash flow (dilution-adjusted): 466000000
Buyback yield (%): 0
Retained earnings: 39003000000
Inventory turnover: 1.605229180116204
Receivables turnover: 5.4416520979020975
Capitalized R&D asset: 3399470000
ROCI (R&D-adjusted, %): 1.5404548561332374
Rosenberg metric: -0.027607361963190184
FCF margin (%): 1.8714107867153928
Revenue growth (%): -11.368570920092543
Rule of 40 score: -9.49716013337715
Financial ratios for WYR.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.18181818181819
Shares outstanding: 103786729
Market cap (USD): 8633168821.363636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WYR.DE — annual report dated 2022-12-31
Total revenue: 3756825000
Gross profit: 1366603000
Operating income: -148870000
Net income: -423856000
Capital expenditures: 312323000
Operating cash flow: -71272000
Depreciation & amortization: 692318000
Net tangible assets: -996091000
Owner earnings: -43861000
Buffett classification: The Gruesome
Stock price: 78.13829787234043
Shares outstanding: 103786729
Book value: -1640365000
Market cap (USD): 8109718345.797873
Debt to equity: -8.371317359246266
Current ratio: 2.2245422521409965
Quick ratio: 2.1858467072572227
Interest coverage ratio: -0.22871935902655616
COGS to revenue (%): 63.62345863861106
SG&A to revenue (%): 22.10510204760669
Free cash flow (dilution-adjusted): -451222000
Buyback yield (%): 2.3120285070954947
Retained earnings: -2711808000
Inventory turnover: 34.10023682483522
Receivables turnover: 17.39005151990668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2829553942254683
FCF margin (%): -12.010727143265923
Rule of 40 score: -12.010727143265923
Financial ratios for WYR.DE — annual report dated 2023-12-31
Total revenue: 6531897000
Gross profit: 2823334000
Operating income: 1075006000
Net income: 782217000
Capital expenditures: 453545000
Operating cash flow: 1247879000
Depreciation & amortization: 687270000
Net tangible assets: -581090000
Owner earnings: 1015942000
Return on net tangible assets (%): -174.8338467363059
Capex to operating income (%): 42.18999707908607
Buffett classification: The Good
Stock price: 109.32222222222222
P/E ratio: 14.50517676227384
Shares outstanding: 103786729
Book value: -1100934000
Market cap (USD): 11346195851.455555
Debt to equity: -12.144312011437561
Current ratio: 1.9276117564829802
Quick ratio: 1.8932770237414642
Effective tax rate (%): -174.0937617167105
Interest coverage ratio: 1.430463241291854
COGS to revenue (%): 56.776201461841794
SG&A to revenue (%): 16.30494173438436
Free cash flow (dilution-adjusted): 729819000
Buyback yield (%): 1.872477813546159
Retained earnings: -2066953000
Inventory turnover: 49.0862319991529
Receivables turnover: 19.115211054923446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.113488065085033
FCF margin (%): 11.173155363594987
Revenue growth (%): 73.86748118424468
Rule of 40 score: 85.04063654783967
Financial ratios for WYR.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 110.14444444444443
Shares outstanding: 103786729
Market cap (USD): 11431531606.41111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WYR.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 103.52083333333333
Shares outstanding: 103786729
Market cap (USD): 10744088675.020832
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WYR.DE — annual report dated 2024-12-31
Total revenue: 7127961000
Gross profit: 3101537000
Operating income: 1357181000
Net income: 639716000
Capital expenditures: 422544000
Operating cash flow: 1426203000
Depreciation & amortization: 658895000
Net tangible assets: -478760000
Owner earnings: 876067000
Return on net tangible assets (%): -182.98667390759462
Capex to operating income (%): 31.133946024885407
Buffett classification: The Good
Stock price: 103.52083333333333
P/E ratio: 16.795091376518382
Shares outstanding: 103786729
Book value: -968603000
Market cap (USD): 10744088675.020832
Debt to equity: -12.559969357930958
Current ratio: 1.897768415637459
Quick ratio: 1.8485437801308708
Effective tax rate (%): 0.5722740822943186
Interest coverage ratio: 1.9714719425923506
COGS to revenue (%): 56.48773892000813
SG&A to revenue (%): 15.158261948964086
Free cash flow (dilution-adjusted): 944630000
Buyback yield (%): 3.7397494766974355
Retained earnings: -1676990000
Inventory turnover: 53.13096604779436
Receivables turnover: 21.998793269468173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.865099656604942
FCF margin (%): 13.252457469955292
Revenue growth (%): 9.125434770327825
Rule of 40 score: 22.377892240283117
Financial ratios for WYR.DE — quarterly report dated 2025-03-31
Total revenue: 1700397000
Gross profit: 718614000
Operating income: 273876000
Net income: 81405000
Capital expenditures: 160231000
Operating cash flow: 133774000
Depreciation & amortization: 155421000
Net tangible assets: -625911000
Owner earnings: 76595000
Return on net tangible assets (%): -12.237362819953637
Capex to operating income (%): 58.50494384319911
Buffett classification: The Good
Stock price: 108.28260869565217
P/E ratio: 34.51353652757415
Shares outstanding: 103786729
Book value: -1101921000
Market cap (USD): 11238297764.108696
Debt to equity: -11.05741609425721
Current ratio: 1.0824655425265823
Quick ratio: 1.048817691959471
Effective tax rate (%): 11.925086825278328
Interest coverage ratio: 1.7377036698644739
COGS to revenue (%): 57.7384575484431
SG&A to revenue (%): 16.213213737733014
Free cash flow (dilution-adjusted): -45857000
Buyback yield (%): 1.8868337932565666
Retained earnings: -1630831000
Inventory turnover: 12.173831636638685
Receivables turnover: 5.090948012598652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.651974402863725
FCF margin (%): -2.6968407965904433
Rule of 40 score: -2.6968407965904433
Financial ratios for WYR.DE — quarterly report dated 2025-06-30
Total revenue: 1737797000
Gross profit: 726206000
Operating income: 275886000
Net income: 76961000
Capital expenditures: 165416000
Operating cash flow: 405062000
Depreciation & amortization: 152907000
Net tangible assets: -679392000
Owner earnings: 64452000
Return on net tangible assets (%): -9.48671753567896
Capex to operating income (%): 59.958098634943426
Buffett classification: The Good
Stock price: 117.49411764705883
P/E ratio: 77.00093547434052
Shares outstanding: 103786729
Book value: -1207974000
Market cap (USD): 12194330147.329412
Debt to equity: -10.074348454519717
Current ratio: 1.0336110558545828
Quick ratio: 1.0003396556890058
Effective tax rate (%): 12.093798901186764
Interest coverage ratio: 1.7850806529883338
COGS to revenue (%): 58.21111441670115
SG&A to revenue (%): 16.15925220264507
Free cash flow (dilution-adjusted): 210809000
Buyback yield (%): 1.3579835710472883
Retained earnings: -1590690000
Inventory turnover: 12.547954551092808
Receivables turnover: 5.32292617482556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6873797302450764
FCF margin (%): 12.130818501815805
Revenue growth (%): 2.199486355245275
Rule of 40 score: 14.33030485706108
Financial ratios for WYR.DE — quarterly report dated 2025-09-30
Total revenue: 1833747000
Gross profit: 756300000
Operating income: 317778000
Net income: 128427000
Capital expenditures: 164074000
Operating cash flow: 335801000
Depreciation & amortization: 152828000
Net tangible assets: -601755000
Owner earnings: 117181000
Return on net tangible assets (%): -19.47320753462788
Capex to operating income (%): 51.63164221563481
Buffett classification: The Good
Stock price: 129.25882352941179
P/E ratio: 46.77711969436452
Shares outstanding: 103786729
Book value: -1141470000
Market cap (USD): 13415350488.505884
Debt to equity: -10.684741605123218
Current ratio: 1.7567392095999446
Quick ratio: 1.695804532921775
Effective tax rate (%): 32.251019449998154
Interest coverage ratio: 2.016600986159499
COGS to revenue (%): 58.75657874286912
SG&A to revenue (%): 14.998524878295644
Free cash flow (dilution-adjusted): 149063000
Buyback yield (%): 0.015027561163812196
Retained earnings: -1528294000
Inventory turnover: 12.264900737637738
Receivables turnover: 5.1997737190884115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.797219170957045
FCF margin (%): 8.128874921131432
Revenue growth (%): 5.521358363491248
Rule of 40 score: 13.65023328462268
Financial ratios for WYR.DE — quarterly report dated 2025-12-31
Total revenue: 1865983000
Gross profit: 755886000
Operating income: 339057000
Net income: 122342000
Capital expenditures: 171169000
Operating cash flow: 478016000
Depreciation & amortization: 159477000
Net tangible assets: -499734000
Owner earnings: 110650000
Return on net tangible assets (%): -22.14177942665498
Capex to operating income (%): 50.48384194987864
Buffett classification: The Good
Stock price: 122.41176470588235
P/E ratio: 31.05262725003037
Shares outstanding: 103786729
Book value: -1031279000
Market cap (USD): 12704716649.941175
Debt to equity: -11.806629437814598
Current ratio: 1.6331286080996703
Quick ratio: 1.579282950477672
Effective tax rate (%): 15.393392853438082
Interest coverage ratio: 2.176008882271397
COGS to revenue (%): 59.491270820795265
SG&A to revenue (%): 15.295584150552283
Free cash flow (dilution-adjusted): 285821000
Buyback yield (%): 0.0035262494421870816
Retained earnings: -1454239000
Inventory turnover: 12.546587852347477
Receivables turnover: 4.634359143753368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9573380198533985
FCF margin (%): 15.31744930152097
Revenue growth (%): 1.7579306196547289
Rule of 40 score: 17.0753799211757
Financial ratios for WYR.DE — annual report dated 2025-12-31
Total revenue: 7137924000
Gross profit: 2957006000
Operating income: 1206597000
Net income: 409135000
Capital expenditures: 660890000
Operating cash flow: 1352653000
Depreciation & amortization: 620633000
Net tangible assets: -499734000
Owner earnings: 368878000
Return on net tangible assets (%): -73.81486951057963
Capex to operating income (%): 54.773051814317455
Buffett classification: The Good
Stock price: 122.41176470588235
P/E ratio: 31.05262725003037
Shares outstanding: 103786729
Book value: -1031279000
Market cap (USD): 12704716649.941175
Debt to equity: -11.806629437814598
Current ratio: 1.6331286080996703
Quick ratio: 1.579282950477672
Effective tax rate (%): 20.42342552612129
Interest coverage ratio: 1.9288393045546681
COGS to revenue (%): 58.573305067411766
SG&A to revenue (%): 15.648135228113944
Free cash flow (dilution-adjusted): 599836000
Buyback yield (%): 2.9918731009381463
Retained earnings: -1454239000
Inventory turnover: 47.253757996338074
Receivables turnover: 17.727762448434213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.524233927454825
FCF margin (%): 8.403507798626043
Revenue growth (%): 0.13977349202668196
Rule of 40 score: 8.543281290652725
Financial ratios for XEL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.51
Shares outstanding: 624269560
Market cap (USD): 36526011955.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XEL — annual report dated 2022-12-31
Total revenue: 15310000000
Gross profit: 5860000000
Operating income: 2428000000
Net income: 1736000000
Capital expenditures: 4638000000
Operating cash flow: 3932000000
Depreciation & amortization: 2554000000
Net tangible assets: 16675000000
Owner earnings: -348000000
Return on net tangible assets (%): -2.086956521739131
Capex to operating income (%): 191.02141680395388
Buffett classification: The Gruesome
Stock price: 62.29
P/E ratio: 22.399626090092166
Shares outstanding: 624269560
Book value: 16675000000
P/B ratio: 2.331979064011994
Market cap (USD): 38885750892.4
Debt to equity: 1.5611394302848576
Current ratio: 0.8463310299440605
Quick ratio: 0.7142152023692004
Effective tax rate (%): -8.432229856339788
Interest coverage ratio: 2.6248648648648647
COGS to revenue (%): 61.72436316133246
Free cash flow (dilution-adjusted): -726000000
Buyback yield (%): 0
Retained earnings: 7239000000
Inventory turnover: 11.768368617683686
Receivables turnover: 6.178369652945924
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.40573398657231
FCF margin (%): -4.7419986936642715
Rule of 40 score: -4.7419986936642715
Financial ratios for XEL — annual report dated 2023-12-31
Total revenue: 14206000000
Gross profit: 5979000000
Operating income: 2588000000
Net income: 1771000000
Capital expenditures: 5854000000
Operating cash flow: 5327000000
Depreciation & amortization: 2567000000
Net tangible assets: 17616000000
Owner earnings: -1516000000
Return on net tangible assets (%): -8.60581289736603
Capex to operating income (%): 226.19783616692425
Buffett classification: The Gruesome
Stock price: 56.88
P/E ratio: 20.049944987464713
Shares outstanding: 624269560
Book value: 17616000000
P/B ratio: 2.0156932659400546
Market cap (USD): 35508452572.8
Debt to equity: 1.5618755676657583
Current ratio: 0.7199221514508138
Quick ratio: 0.5941259731068649
Effective tax rate (%): -8.984615384615385
Interest coverage ratio: 2.5776892430278884
COGS to revenue (%): 57.9121497958609
Free cash flow (dilution-adjusted): -552000000
Buyback yield (%): 0
Retained earnings: 7858000000
Inventory turnover: 11.571026722925458
Receivables turnover: 6.552583025830258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.429458983004433
FCF margin (%): -3.88568210615233
Revenue growth (%): -7.21097322011757
Rule of 40 score: -11.0966553262699
Financial ratios for XEL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.79
Shares outstanding: 624269560
Market cap (USD): 38573616112.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XEL — annual report dated 2024-12-31
Total revenue: 13441000000
Gross profit: 6148000000
Operating income: 2386000000
Net income: 1936000000
Capital expenditures: 7364000000
Operating cash flow: 4641000000
Depreciation & amortization: 2875000000
Net tangible assets: 19522000000
Owner earnings: -2553000000
Return on net tangible assets (%): -13.077553529351501
Capex to operating income (%): 308.6336965632858
Buffett classification: The Gruesome
Stock price: 63.89
P/E ratio: 20.601540386570246
Shares outstanding: 624269560
Book value: 19522000000
P/B ratio: 2.0430582004097944
Market cap (USD): 39884582188.4
Debt to equity: 1.5473824403237373
Current ratio: 0.6696082984982196
Quick ratio: 0.5664963616658926
Effective tax rate (%): -26.205997392438068
Interest coverage ratio: 2.018612521150592
COGS to revenue (%): 54.259355702700695
Free cash flow (dilution-adjusted): -2756000000
Buyback yield (%): 0
Retained earnings: 8553000000
Inventory turnover: 10.95045045045045
Receivables turnover: 6.458913983661701
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7529885491380393
FCF margin (%): -20.50442675396176
Revenue growth (%): -5.385048571026327
Rule of 40 score: -25.889475324988087
Financial ratios for XEL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 63.89
Shares outstanding: 624269560
Market cap (USD): 39884582188.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XEL — quarterly report dated 2025-03-31
Total revenue: 3906000000
Gross profit: 1685000000
Operating income: 677000000
Net income: 483000000
Capital expenditures: 1988000000
Operating cash flow: 1028000000
Depreciation & amortization: 763000000
Net tangible assets: 19804000000
Owner earnings: -742000000
Return on net tangible assets (%): -3.7467178347808523
Capex to operating income (%): 293.6484490398818
Buffett classification: The Gruesome
Stock price: 68.11
P/E ratio: 22.007763836231884
Shares outstanding: 624269560
Book value: 19804000000
P/B ratio: 2.1469904934154718
Market cap (USD): 42518999731.6
Debt to equity: 1.632296505756413
Current ratio: 0.796321020620086
Quick ratio: 0.7036048064085447
Effective tax rate (%): -14.454976303317535
Interest coverage ratio: 2.190938511326861
COGS to revenue (%): 56.86123911930363
Free cash flow (dilution-adjusted): -969000000
Buyback yield (%): 0
Retained earnings: 8706000000
Inventory turnover: 3.5536
Receivables turnover: 1.899805447470817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0256332565749606
FCF margin (%): -24.807987711213517
Rule of 40 score: -24.807987711213517
Financial ratios for XEL — quarterly report dated 2025-06-30
Total revenue: 3287000000
Gross profit: 1559000000
Operating income: 577000000
Net income: 444000000
Capital expenditures: 2427000000
Operating cash flow: 1081000000
Depreciation & amortization: 753000000
Net tangible assets: 20961000000
Owner earnings: -1230000000
Return on net tangible assets (%): -5.868040646915701
Capex to operating income (%): 420.6239168110918
Buffett classification: The Gruesome
Stock price: 66.06
P/E ratio: 44.486782236893205
Shares outstanding: 624269560
Book value: 20961000000
P/B ratio: 1.9674274668956633
Market cap (USD): 41239247133.6
Debt to equity: 1.5899050617814035
Current ratio: 0.9627930682976554
Quick ratio: 0.8493034318722392
Effective tax rate (%): -15.625
Interest coverage ratio: 1.7919254658385093
COGS to revenue (%): 52.5707331913599
Free cash flow (dilution-adjusted): -1358000000
Buyback yield (%): 0
Retained earnings: 8813000000
Inventory turnover: 2.586826347305389
Receivables turnover: 1.6813299232736574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8308015723315718
FCF margin (%): -41.314268329784
Revenue growth (%): -15.847414234511009
Rule of 40 score: -57.161682564295006
Financial ratios for XEL — quarterly report dated 2025-09-30
Total revenue: 3915000000
Gross profit: 2059000000
Operating income: 1036000000
Net income: 524000000
Capital expenditures: 3055000000
Operating cash flow: 1765000000
Depreciation & amortization: 787000000
Net tangible assets: 21181000000
Owner earnings: -1744000000
Return on net tangible assets (%): -8.233794438411785
Capex to operating income (%): 294.8841698841699
Buffett classification: The Gruesome
Stock price: 78.85
P/E ratio: 33.923952312887664
Shares outstanding: 624269560
Book value: 21181000000
P/B ratio: 2.323953298050139
Market cap (USD): 49223654806
Debt to equity: 1.6770690713375194
Current ratio: 0.7947677672076106
Quick ratio: 0.6936205931729155
Effective tax rate (%): 1.5037593984962405
Interest coverage ratio: 2.9770114942528734
COGS to revenue (%): 47.40740740740741
Free cash flow (dilution-adjusted): -1307000000
Buyback yield (%): 0
Retained earnings: 8995000000
Inventory turnover: 2.567081604426003
Receivables turnover: 1.9458250497017893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4387689914729327
FCF margin (%): -33.384418901660275
Revenue growth (%): 19.105567386674778
Rule of 40 score: -14.278851514985497
Financial ratios for XEL — annual report dated 2025-12-31
Total revenue: 14669000000
Gross profit: 6924000000
Operating income: 2879000000
Net income: 2018000000
Capital expenditures: 10908000000
Operating cash flow: 4083000000
Depreciation & amortization: 3082000000
Net tangible assets: 23609000000
Owner earnings: -5808000000
Return on net tangible assets (%): -24.600787835147614
Capex to operating income (%): 378.88155609586664
Buffett classification: The Gruesome
Stock price: 72.77
P/E ratio: 22.511444936174428
Shares outstanding: 624269560
Book value: 23609000000
P/B ratio: 1.924185517438265
Market cap (USD): 45428095881.2
Debt to equity: 1.4732093693083146
Current ratio: 0.7072929891381012
Quick ratio: 0.599943574552123
Effective tax rate (%): -13.818386914833617
Interest coverage ratio: 2.1437081161578555
COGS to revenue (%): 52.79841843343105
Free cash flow (dilution-adjusted): -6871000000
Buyback yield (%): 0
Retained earnings: 9207000000
Inventory turnover: 10.177398160315375
Receivables turnover: 6.637556561085973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8757707116125037
FCF margin (%): -46.84027541073011
Revenue growth (%): 9.136224983260174
Rule of 40 score: -37.70405042746994